S.E.E.D. Planning Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,332
Closed -$222K 86
2022
Q3
$222K Sell
2,332
-63
-3% -$6.24K 0.1% 71
2022
Q2
$222K Sell
2,395
-230
-9% -$22.4K 0.1% 73
2022
Q1
$266K Sell
2,625
-134
-5% -$14.1K 0.11% 72
2021
Q4
$285K Sell
2,759
-2
-0.1% -$185 0.12% 69
2021
Q3
$234K Sell
2,761
-64
-2% -$5.36K 0.11% 73
2021
Q2
$236K Sell
2,825
-17
-0.6% -$1.39K 0.12% 75
2021
Q1
$214K Sell
2,842
-9,888
-78% -$720K 0.12% 72
2020
Q4
$869K Buy
12,730
+8,237
+183% +$536K 0.52% 42
2020
Q3
$262K Buy
+4,493
New +$280K 0.19% 56

Other funds holding CVS

S.E.E.D. Planning Group's CVS Position: Q4 2022 in Review

S.E.E.D. Planning Group sold out of CVS Health (CVS) in Q4 2022, closing a stake of 2,332 shares — an estimated $222K sold.

S.E.E.D. Planning Group first reported a position in CVS in Q3 2020 and held it in 9 quarters. The position peaked at $869K in Q4 2020. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • S.E.E.D. Planning Group reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • S.E.E.D. Planning Group sold 2,332 CVS Health shares in Q4 2022, an estimated $222K.
  • S.E.E.D. Planning Group first reported a position in CVS Health in Q3 2020 and held it in 9 quarters.
  • S.E.E.D. Planning Group's CVS Health position peaked at $869K in Q4 2020.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on S.E.E.D. Planning Group's 13F filing for Q4 2022, filed 19 Jan 2023.